Posted by Michael Wonder on 29 Jul 2024
Life changing medicine for children with cystic fibrosis
29 July 2024 - Australian children with cystic fibrosis now have access to cheaper medicines earlier under the PBS thanks to the Australian Government.
Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) will be expanded to include children aged 2 to 5 years with cystic fibrosis who have at least one F508del mutation on the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the most common CF causing mutation worldwide.
